Findings

What do systematic reviews say?

4,703 questions · 15,007 findings · 1,416 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2,881 · 19.2%GRADE not reported 1,551 · 10.3%Very low 3,111 · 20.7%Low 3,881 · 25.9%Moderate 2,669 · 17.8%High 914 · 6.1%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

PUFA vs placebo

ADHD symptoms – improvement – medium term · Children and adolescents with ADHD

Summary of findings table ‐ PUFA may leads to higher ADHD symptoms – improvement – medium term compared with placebo (low certainty).

1 finding from 1 review

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents 2023 · Cochrane Headline outcomes only
RR 1.95 [1.47, 2.6]
3 studies · 191 participants
Low

PUFA vs placebo

ADHD symptoms · Children and adolescents with ADHD

1 finding from 1 review

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents 2023 · Cochrane Headline outcomes only
no estimate extracted
16 studies · 1166 participants
High

PUFA vs placebo

ADHD symptoms – inattention, parent‐rated – medium term · Children and adolescents with ADHD

1 finding from 1 review

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents 2023 · Cochrane Headline outcomes only
no estimate extracted
12 studies · 960 participants
High

PUFA vs placebo

ADHD symptoms – hyperactivity/impulsivity, parent‐rated – medium term · Children and adolescents with ADHD

1 finding from 1 review

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents 2023 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 869 participants
High

PUFA vs placebo

Side effects – overall · Children and adolescents with ADHD

Summary of findings table ‐ PUFA showed no clear difference in side effects – overall compared with placebo (moderate certainty).

1 finding from 1 review

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents 2023 · Cochrane Headline outcomes only
RR 1.02 [0.69, 1.52]
8 studies · 591 participants
Moderate

PUFA vs placebo

Loss to · Children and adolescents with ADHD

Summary of findings table ‐ PUFA showed no clear difference in loss to compared with placebo (moderate certainty).

1 finding from 1 review

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents 2023 · Cochrane Headline outcomes only
RR 1.03 [0.77, 1.37]
13 studies · 1121 participants
Moderate

Omeprazole vs placebo

Improvement in symptoms in infants · GORD in infants

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Esomeprazole vs placebo

Adverse events ‐ not reported · GORD in infants

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Esomeprazole vs placebo

pH indices ‐ not measured · GORD in infants

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Esomeprazole vs placebo

Endoscopic metrics ‐ not measured · GORD in infants

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Omeprazole vs placebo

Adverse events ‐ not reported · GORD in infants

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Omeprazole vs placebo

Improvement in pH metrics in infants · GORD in infants

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Omeprazole vs placebo

Endoscopic metrics ‐ not measured · GORD in infants

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Esomeprazole vs placebo

Improvement in symptoms and signs in infants · GORD in infants

1 finding from 1 review

Pharmacological treatment of gastro‐oesophageal reflux in children 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 52 participants
Very low

Statins vs placebo

Resumption of menstrual regularity · women with polycystic ovary syndrome not actively trying to conceive

1 finding from 1 review

Statins for women with polycystic ovary syndrome not actively trying to conceive 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 37 participants
Very low

Statins vs placebo

Resumption of spontaneous ovulation · women with polycystic ovary syndrome not actively trying to conceive

The review found no eligible studies for this question.

1 finding from 1 review

Statins for women with polycystic ovary syndrome not actively trying to conceive 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Statins vs placebo

Clinician's assessment of improvement of hirsutism Ferriman‐Gallwey score Scale from: 0 to 36 · women with polycystic ovary syndrome not actively trying to conceive

The review found no eligible studies for this question.

1 finding from 1 review

Statins for women with polycystic ovary syndrome not actively trying to conceive 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Statins vs placebo

Improvement in acne severity · women with polycystic ovary syndrome not actively trying to conceive

The review found no eligible studies for this question.

1 finding from 1 review

Statins for women with polycystic ovary syndrome not actively trying to conceive 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Statins vs placebo

Improvement in testosterone level (nmol/L) after 6 months' treatment · women with polycystic ovary syndrome not actively trying to conceive

1 finding from 1 review

Statins for women with polycystic ovary syndrome not actively trying to conceive 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Statins vs placebo

Adverse effects · women with polycystic ovary syndrome not actively trying to conceive

1 finding from 1 review

Statins for women with polycystic ovary syndrome not actively trying to conceive 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 2 participants
GRADE not reported